Studies have shown that blockade of TIGIT restores NK cell exhaustion and promotes NK cell-dependent tumor immunity, enhancing degranulation and IFN-γ production in healthy donor CD56dim NK cells. The gene discussed is TIGIT; the disease is neoplasm.